ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,239Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 2056

$468K Total Retail Price of All Prescriptions

Rank: 90 out of 2056

312 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 312 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

16% of this provider’s 312 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 7,987 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 543 461 1 1
SIMVASTATIN 393 272 2 2
AMLODIPINE BESYLATE 324 291 3 6
ALENDRONATE SODIUM 309 290 4 26
FUROSEMIDE 295 273 5 9
LEVOTHYROXINE SODIUM 290 225 6 3
OMEPRAZOLE 274 204 7 4
ATENOLOL 238 212 8 10
HYDROCHLOROTHIAZIDE 204 191 9 7
METOPROLOL TARTRATE 194 189 10 11
ZOLPIDEM TARTRATE 190 155 11 23
METFORMIN HCL 178 157 12 8
VOLTAREN 173 165 13 182
GABAPENTIN 154 119 14 14
CITALOPRAM HBR 150 114 15 15
POTASSIUM CHLORIDE 149 138 16 18
LOSARTAN POTASSIUM 148 130 17 13
ATORVASTATIN CALCIUM 145 120 18 17
LOVASTATIN 142 124 19 16
PROAIR HFA 134 72 20 29
RANITIDINE HCL 124 106 21 22
TRIAMCINOLONE ACETONIDE 119 104 22 81
CRESTOR 111 93 23 30
HYDROCODONE-ACETAMINOPHEN 110 81 S3 24 5
TRAZODONE HCL 109 80 25 21
SPIRIVA 97 63 26 42
KETOCONAZOLE 96 64 27 199
WARFARIN SODIUM 95 66 28 12
ALLOPURINOL 95 84 28 32
SERTRALINE HCL 89 72 30 25
GLIPIZIDE 86 61 31 39
METOPROLOL SUCCINATE 82 60 32 19
NITROSTAT 80 69 33 202
TAMSULOSIN HCL 77 51 34 28
ESCITALOPRAM OXALATE 72 47 35 118
PLAVIX 65 63 36 131
ISOSORBIDE MONONITRATE 65 65 36 316
DICLOFENAC SODIUM 65 61 36 95
LIDODERM 64 56 39 99
ADVAIR DISKUS 63 29 40 51
JANUVIA 63 51 40 121
METFORMIN HCL ER 62 49 42 43
ACETAMINOPHEN-CODEINE 60 47 S3 43 88
GLIMEPIRIDE 58 56 44 67
DONEPEZIL HCL 58 58 44 37
ISOSORBIDE MONONITRATE ER 56 42 46 87
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 51 47 34
NEXIUM 53 48 48 71
CLOPIDOGREL 53 51 48 72
BENICAR 52 52 50 156
PANTOPRAZOLE SODIUM 51 29 51 55
ENALAPRIL MALEATE 50 49 52 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.